These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 681801)
21. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive. Brown SD; Barbara AJ; Lambert T; Wilson DV Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247 [TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay for the detection of hepatitis e antigen (HBeAG) and antibody (anti-HBe). Fields HA; Bradley DW; Davis CL; Murphy BL; Schable CA; Maynard JE J Immunol; 1978 Sep; 121(3):930-5. PubMed ID: 80434 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity. Salawu L; Adegoke AO; Aboderin AO; Huraina HA West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations. Szmuness W; Neurath AR; Stevens CE; Strick N; Harley EJ Am J Epidemiol; 1981 Feb; 113(2):113-21. PubMed ID: 7468569 [TBL] [Abstract][Full Text] [Related]
25. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis. Babeş VT; Tănase M; Cepănaru S; Cepănaru R Virologie; 1981; 32(2):93-8. PubMed ID: 6787796 [TBL] [Abstract][Full Text] [Related]
26. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction? Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304 [TBL] [Abstract][Full Text] [Related]
27. Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir. de Niet A; Jansen L; Zaaijer HL; Klause U; Takkenberg B; Janssen HL; Chu T; Petric R; Reesink HW Antivir Ther; 2014; 19(3):259-67. PubMed ID: 24256626 [TBL] [Abstract][Full Text] [Related]
28. Assessment of infectiousness of male Malaysian blood donors. So-Har T; Gladys LC; Ramli N Vox Sang; 1983; 45(5):389-91. PubMed ID: 6636661 [TBL] [Abstract][Full Text] [Related]
29. Confirmatory evidence for the association of hepatitis B surface antigen with antigenic determinants reactive with antibodies present in some anti-HBe-positive sera. Neurath AR; Strick N; Huang CY J Gen Virol; 1980 May; 48(1):53-61. PubMed ID: 6155434 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. Twagirumugabe T; Swaibu G; Walker TD; Lindh M; Gahutu JB; Bergström T; Norder H BMC Infect Dis; 2017 Jan; 17(1):32. PubMed ID: 28056881 [TBL] [Abstract][Full Text] [Related]
31. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion. Babeş VT; Cepănaru S; Cepănaru R; Tănase M Virologie; 1981; 32(3):187-91. PubMed ID: 7303492 [TBL] [Abstract][Full Text] [Related]
32. Investigations on HBe antigen. Note III. HBe system and sex-dependent clearance of HBsAg subtypes. Babeş VT; Blană D; Duiculescu D; Cepănaru S Virologie; 1981; 32(4):261-8. PubMed ID: 7331232 [TBL] [Abstract][Full Text] [Related]
33. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers. Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629 [TBL] [Abstract][Full Text] [Related]
34. Radioimmunoassay for the detection of HBeAg and anti-HBe. Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390 [TBL] [Abstract][Full Text] [Related]
35. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B. Sällberg M; Norder H; Lindh G; Magnius LO Clin Exp Immunol; 1991 Apr; 84(1):116-21. PubMed ID: 2015701 [TBL] [Abstract][Full Text] [Related]
36. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers]. Chang ML; Chou CT; Lee CF; Chang DM Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466 [TBL] [Abstract][Full Text] [Related]
37. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B. Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus DNA in patients with HBsAg in south western Nigeria. Odaibo GN; Ola SO; Olaleye OD J Med Virol; 2013 Feb; 85(2):214-8. PubMed ID: 23161583 [TBL] [Abstract][Full Text] [Related]
39. [e/Anti-e system in liver disease]. Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers. Beutner KR; Tiku ML; Ogra PL Infect Immun; 1978 Aug; 21(2):480-8. PubMed ID: 80380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]